Cytokine-based therapy with IL-12 has also demonstrated to reinvigorate CD8 expansion during PD-1 blockade (unpublished observation)
Cytokine-based therapy with IL-12 has also demonstrated to reinvigorate CD8 expansion during PD-1 blockade (unpublished observation). towards CD8 effector anti-tumor reactions in malignancy; and particularly, we focus on the recently published studies uncovering the key contribution of systemic CD4 T cells to medical effectiveness in PD-L1/PD-1 blockade treatments. We conclude and propose that the presence…